Emerging studies suggest Retatru tide , a dual stimulator targeting both incretin and GIP , appears to provide a significant step forward for weight management . Preliminary human trials have demonstrated considerable reductions in abdominal mass , potentially surpassing other weight-loss treatments. However , more study is needed to completely und